These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 22108478)
21. Doubling daily inhaled corticosteroid dose is ineffective in mild to moderately severe attacks of asthma in adults. Rice-McDonald G; Bowler S; Staines G; Mitchell C Intern Med J; 2005 Dec; 35(12):693-8. PubMed ID: 16313543 [TBL] [Abstract][Full Text] [Related]
22. Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma. Masoli M; Weatherall M; Holt S; Beasley R Thorax; 2005 Sep; 60(9):730-4. PubMed ID: 16135679 [TBL] [Abstract][Full Text] [Related]
23. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715 [TBL] [Abstract][Full Text] [Related]
24. Comparison of three treatment regimens of inhaled sodium cromoglycate in the management of adult patients with severe, steroid-dependent asthma. Sakai H; Shimoda T; Matsuo N; Matsuse H; Obase Y; Asai S; Kohno S; Edwards A Ann Allergy Asthma Immunol; 1998 Jun; 80(6):494-8. PubMed ID: 9647273 [TBL] [Abstract][Full Text] [Related]
25. [Inhaled corticosteroid therapy in adults with asthma. Current evidences]. Foresi A; Pelucchi A; Del Donno M; Marangio E; Olivieri D Recenti Prog Med; 2005 Oct; 96(10):469-73. PubMed ID: 16491767 [TBL] [Abstract][Full Text] [Related]
26. Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study. Niven R; Chung KF; Panahloo Z; Blogg M; Ayre G Respir Med; 2008 Oct; 102(10):1371-8. PubMed ID: 18657960 [TBL] [Abstract][Full Text] [Related]
27. House dust mite allergen avoidance and self-management in allergic patients with asthma: randomised controlled trial. de Vries MP; van den Bemt L; Aretz K; Thoonen BP; Muris JW; Kester AD; Cloosterman S; van Schayck CP Br J Gen Pract; 2007 Mar; 57(536):184-90. PubMed ID: 17359604 [TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma. LaForce CF; Pearlman DS; Ruff ME; Silvers WS; Weinstein SW; Clements DS; Brown A; Duke S; Harding SM; House KW Ann Allergy Asthma Immunol; 2000 Nov; 85(5):407-15. PubMed ID: 11101186 [TBL] [Abstract][Full Text] [Related]
29. Improvement in signs and symptoms in psoriasis patients with Pycnogenol® supplementation. Belcaro G; Luzzi R; Hu S; Cesarone MR; Dugall M; Ippolito E; Corsi M; Caporale S Panminerva Med; 2014 Mar; 56(1):41-8. PubMed ID: 24637472 [TBL] [Abstract][Full Text] [Related]
31. [Therapeutic efficacy of 3-year subcutaneous immunotherapy in asthmatic children allergic to mite]. Li L; Hui Y; Qian J; Guo Y; Zhang XL; Zhang XJ Zhongguo Dang Dai Er Ke Za Zhi; 2013 May; 15(5):368-71. PubMed ID: 23676940 [TBL] [Abstract][Full Text] [Related]
32. [Effect of house dust mite vaccine on pulmonary function and inhaled corticosteroid doses in children with allergic asthma]. Ye Z; Huang Y; Wang Y; Gong C; Jiang Y Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov; 32(11):1632-5. PubMed ID: 23174592 [TBL] [Abstract][Full Text] [Related]
33. Impact of inhaled corticosteroid treatment on 15-year longitudinal respiratory function changes in adult patients with bronchial asthma. Shimoda T; Obase Y; Kishikawa R; Iwanaga T Int Arch Allergy Immunol; 2013; 162(4):323-9. PubMed ID: 24193229 [TBL] [Abstract][Full Text] [Related]
34. Superiority of nebulized corticosteroids over dry powder inhalers in certain patients with cough variant asthma or cough-predominant asthma. Kamimura M; Izumi S; Hamamoto Y; Morita A; Toyota E; Kobayashi N; Kudo K Allergol Int; 2012 Sep; 61(3):411-7. PubMed ID: 22627846 [TBL] [Abstract][Full Text] [Related]
35. Markers for step-down of inhaled corticosteroid therapy in adult asthmatics. Tsurikisawa N; Oshikata C; Tsuburai T; Mitsui C; Tanimoto H; Takahashi K; Sekiya K; Nakazawa T; Minoguchi K; Otomo M; Maeda Y; Saito H; Akiyama K Allergol Int; 2012 Sep; 61(3):419-29. PubMed ID: 22722811 [TBL] [Abstract][Full Text] [Related]
37. Pycnogenol® and Centella asiatica in the management of asymptomatic atherosclerosis progression. Belcaro G; Ippolito E; Dugall M; Hosoi M; Cornelli U; Ledda A; Scoccianti M; Steigerwalt RD; Cesarone MR; Pellegrini L; Luzzi R; Corsi M Int Angiol; 2015 Apr; 34(2):150-7. PubMed ID: 25519846 [TBL] [Abstract][Full Text] [Related]
38. [Changes in treatment, symptoms and QOL of pediatric asthma patients at different ages for 7 years in Tochigi]. Yoshihara S; Morimoto S; Momoi M; Eguchi M; Ihara M; Kanno N; Hirao J; Arisaka O Arerugi; 2012 Jan; 61(1):30-40. PubMed ID: 22398426 [TBL] [Abstract][Full Text] [Related]
39. Inhaled corticosteroids and asthma control in adult-onset asthma: 12-year follow-up study. Vähätalo I; Ilmarinen P; Tuomisto LE; Niemelä O; Kankaanranta H Respir Med; 2018 Apr; 137():70-76. PubMed ID: 29605216 [TBL] [Abstract][Full Text] [Related]
40. Prevention and control of jet lag symptoms and temporary impairment of cognitive function with Pycnogenol® in healthy individuals and in hypertensives. Belcaro G; Hu S; Hosoi M; Cesarone MR; Ledda A; Dugall M; Cornelli U; Saggino A; Cotellese R; Feragalli B; Cox D; Peterzan P; Scipione C; Scipione V Minerva Med; 2024 Apr; 115(2):178-184. PubMed ID: 38197571 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]